<DOC>
	<DOC>NCT00165724</DOC>
	<brief_summary>Open study for efficacy and safety of donepezil treatment during 48 weeks</brief_summary>
	<brief_title>Alzheimer's Disease Long-term Follow-up Study (ALF Study)</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Inclusion criteria Men or women aged 40 to 90 Diagnosis of dementia according to DSMIV Diagnosis of probable AD as defined by NINCDSADRDA criteria Mild to moderate AD at baseline, as defined by MMSE score of 10 to 26 Patients were generally healthy and ambulatory or ambulatory aided Patients did not take acetylcholinesterase inhibitor 4 weeks before screening Patients have useful MRI results 3 months before screening Exclusion If they have evidence of TIA or major infarction Epilepsy patients If they have evidence of other degenerative or psychiatric disorder, other serious disorder, alcoholism or drug abuse If they sensitive to acetylcholinesterase If they taken concomitant medication which were not allowed</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>